98%
921
2 minutes
20
A breast cancer diagnosis may result in disabling effects which may persist after treatment. The aim of this study was to identify patient factors that are associated with increased cancer worry, fatigue, and impact on work. Women with a history of breast cancer, aged ≥18 years, and English-speaking were recruited through the Love Research Army between October and November 2019. Participants completed demographic and clinical questions alongside the BREAST-Q Cancer Worry, Fatigue, and Impact on Work scales. Univariable and multivariable regression analyses were used to identify participant characteristics associated with each scale. Cancer Worry, Fatigue, and Impact on Work scales were completed by = 1680, = 1037, and = 873 participants, respectively. Most participants were older than 50 ( = 1,470, 87.5%), married ( = 1229, 73.2%), white ( = 1557, 92.7%), and had undergone surgery for cancer treatment ( = 1,472, 87.6%). Increased Cancer Worry was significantly associated ( < .04) with younger age, less time since diagnosis, pain related to cancer/treatment, recurrence, prior chemotherapy, and ongoing breast edema. Increased Fatigue was significantly associated ( < .01) with elevated BMI, less time since diagnosis, ethnicity, employment status, recurrence, prior chemotherapy, ongoing pain, and difficulty sleeping secondary to treatment. Decreased Impact on Work scores was significantly associated ( < .04) with chemotherapy administration, shorter time since diagnosis, employment, fatigue related to treatment, breast edema, and ongoing pain. This study reveals patient characteristics associated with increased cancer worry, fatigue, and a negative impact on work following a breast cancer diagnosis. These findings can inform clinical and research initiatives to better support patients through treatment and survivorship.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11490967 | PMC |
http://dx.doi.org/10.1177/22925503231161067 | DOI Listing |
Adv Clin Exp Med
September 2025
Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Background: Research on the psychological distress experienced by women with benign breast disease (BBD) remains limited, though some evidence suggests it may resemble that of women with breast cancer (BC).
Objectives: This study aimed to use the Distress Thermometer (DT) to assess the levels of psychological distress and identify influencing factors during the diagnostic phase in patients with BC and BBD.
Material And Methods: From October 2022 to May 2023, a questionnaire survey incorporating the DT and Problem List (PL) was conducted among inpatients in the diagnostic phase for BC or BBD at the Breast Surgery Department of Shanxi Bethune Hospital (Taiyuan, China).
Eur J Breast Health
September 2025
University of Miami Hospital, Department of Radiology, Division of Breast Imaging, Miami, USA.
Screening mammography plays a critical role in the early detection of breast cancer. Suspicious breast calcifications on mammography often prompt further diagnostic evaluation due to concern for malignancy, worrying physicians and patients alike. Here, we present a case of a woman in her 70s whose annual screening mammogram with digital breast tomosynthesis demonstrated two new groups of microcalcifications, confirmed after recall with magnification views.
View Article and Find Full Text PDFSupport Care Cancer
September 2025
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Purpose: The impact of a cancer diagnosis on racial differences in financial well-being and treatment related financial toxicity has not been well characterized. The purpose of this study was to compare relative disparities in financial distress by race among respondents with and without a history of cancer.
Methods: We performed a retrospective cohort study based on the National Health Interview Survey (2010 to 2018).
J Cancer Surviv
September 2025
Massachusetts General Hospital, 100 Cambridge St., 16Th Floor, Boston, MA, 02114, USA.
Purpose: After a cancer diagnosis, uncertainty is common. IN FOCUS is a pilot randomized controlled trial that evaluated the feasibility and acceptability of a virtual mind-body group resiliency intervention on fear of cancer recurrence (FCR). The current study examines secondary outcomes of this trial, specifically exploring changes in related mental health constructs, which will contribute to our understanding of symptom relief as well as diagnostic overlap and discrepancies.
View Article and Find Full Text PDFJ Cancer Surviv
August 2025
Hematology Department, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Background: A second allogeneic hematopoietic stem cell transplantation (allo-HSCT) is often the most effective treatment option for patients experiencing graft failure or disease relapse following a first round of allo-HSCT. Unfortunately, the consent rate for second donation is insufficient to meet treatment needs worldwide. The purpose of this study was to provide a comprehensive understanding of the decision-making experience of unrelated donors when considering making a second donation.
View Article and Find Full Text PDF